VJDementia is committed to improving our service to you

Share this video  

VJDementia is committed to improving our service to you

EAN 2020 | Alzheimer’s disease: what are the challenges when disease-modifying therapies become available?

Paola Barbarino • 26 May 2020
EAN 2020
Alzheimer’s Disease Dementia

Paola Barbarino, CEO, Alzheimer’s Disease International, outlines the challenges to prepare healthcare systems for the diagnosis, treatment, and care of Alzheimer’s disease in a future with disease-modifying therapies. This interview was recorded during an online conference call with The Video Journal of Dementia (VJDementia).

More from Paola Barbarino

5:16
Post-COVID-19 dementia landscape
Paola Barbarino • 26 May 2020
5:47
Is the world prepared for dementia?
Paola Barbarino • 26 May 2020
4:20
Dementia care during the COVID-19 pandemic
Paola Barbarino • 26 May 2020

Related Videos

2:27
EAN guidance on managing patients with dementia
Kristian Steen Frederiksen • 20 Nov 2020
4:05
Medical management issues in dementia: recommendations
Kristian Steen Frederiksen • 20 Nov 2020
3:08
Dementia, stress and the molecular age of the brain
Luiza Spiru • 31 Oct 2020
3:00
A673T mutation lowers Aβ oligomer binding affinity: Alzheimer’s disease protective mechanism
Susan Catalano • 27 Oct 2020
The content of VJDementia is intended for healthcare professionals